Gold nanoparticles inhibit vascular endothelial growth factor-induced angiogenesis and vascular permeability via Src dependent pathway in retinal endothelial cells

Angiogenesis

Volumn 14, Issue 1, 2011, Pages 29-45

  Kalishwaralal, Kalimuthu ^a   Sheikpranbabu, Sardarpasha ^a   Barathmanikanth, Selvaraj ^a   Haribalaganesh, Ravinarayanan ^a   Ramkumarpandian, Sureshbabu ^a   Gurunathan, Sangiliyandi ^a  

^a KALASALINGAM UNIVERSITY   (India)

Author keywords

Gold nanoparticles; Retinal neovascularization; Src pathway; VEGF

Indexed keywords

DEXTRAN; GOLD NANOPARTICLE; PROTEIN TYROSINE KINASE INHIBITOR; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN 165B; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; BLOOD VESSEL PERMEABILITY; CELL LYSATE; CELL MIGRATION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; COW; DRUG INHIBITION; ENDOTHELIUM CELL; MOLECULAR DYNAMICS; NONHUMAN; PERMEABILITY; PLASMID; PRIORITY JOURNAL; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; RETINA BLOOD VESSEL; RETINA NEOVASCULARIZATION; SIGNAL TRANSDUCTION; TRANSMISSION ELECTRON MICROSCOPY; WESTERN BLOTTING;

ANIMALS; BIOLOGICAL ASSAY; CAPILLARY PERMEABILITY; CATTLE; CELL MEMBRANE PERMEABILITY; CELL MOVEMENT; CELL PROLIFERATION; DEXTRANS; ENDOTHELIAL CELLS; GOLD; HUMANS; METAL NANOPARTICLES; NEOVASCULARIZATION, PHYSIOLOGIC; PHOSPHORYLATION; RETINA; RHODAMINES; SIGNAL TRANSDUCTION; SRC-FAMILY KINASES; TRANSFECTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

BOVINAE;

EID: 79952282375     PISSN: 09696970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10456-010-9193-x     Document Type: Article

References (48)

1. P Carmeliet 2000 VEGF gene therapy: stimulating angiogenesis or angioma-genesis? Nat Med 6 1102 1103 1:CAS:528:DC%2BD3cXntlKnsbs%3D 10.1038/80430 11017137
2. MJ Cross L Claesson-Welsh 2001 FGF and VEGF function in angiogenesis: signaling pathways, biological responses and therapeutic inhibition Trends Pharmacol Sci 22 201 207 1:CAS:528:DC%2BD3MXit1Wntr8%3D 10.1016/S0165-6147(00) 01676-X 11282421 (Pubitemid 32244307)
3. LP Aiello RL Avery PG Arrigg AK Bruce DJ Henry TS Sabera 1994 Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders N Engl J Med 331 1480 1487 1:STN:280: DyaK2M%2FlvFamsA%3D%3D 10.1056/NEJM199412013312203 7526212 (Pubitemid 24356306)
4. Y Hata K Nakagawa T Ishibashi H Inomata H Ueno K Sueishi 1995 Hypoxia-induced expression of vascular endothelial growth factor by retinal glial cells promotes in vitro angiogenesis Virchows Arch 426 479 486 1:CAS:528:DyaK2MXosVaquro%3D 10.1007/BF00193171 7543339
5. N Ferrara 2002 VEGF and the quest for tumour angiogenesis factors Nat Rev Cancer 2 795 803 1:CAS:528:DC%2BD38XnsVGrtbk%3D 10.1038/nrc909 12360282 (Pubitemid 37328914)
6. N Ferrara T Davis-Smyth 1997 The biology of vascular endothelial growth factor Endocr Rev 18 4 25 1:CAS:528:DyaK2sXhsFCiu7s%3D 10.1210/er.18.1.4 9034784 (Pubitemid 27076453)
7. B Millauer S Wizigmann-Voos H Schnurch R Martinez NP Moller W Risau 1993 High-affinity VEGF binding and developmental expression suggests Flk-1 as a major regulator of vasculogenesis and angiogenesis Cell 72 835 846 1:CAS:528:DyaK3sXks1egsb8%3D 10.1016/0092-8674(93)90573-9 7681362 (Pubitemid 23110226)
8. F Shalaby J Rossant TP Yamaguchi M Gertsenstein XF Wu ML Breitman 1995 Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice Nature 376 62 66 1:CAS:528:DyaK2MXmvVKjsro%3D 10.1038/376062a0 7596435
9. BQ Shen DY Lee TF Zioncheck 1999 Vascular endothelial growth factor governs endothelial nitric-oxide synthase expression via a KDR/Flk-1 receptor and a protein kinase C signaling pathway J Biol Chem 274 33057 33063 1:CAS:528:DyaK1MXntlygu70%3D 10.1074/jbc.274.46.33057 10551875 (Pubitemid 129535347)
10. ZF Bashshur A Bazarbachi A Schakal ZA Haddad CP El Haibi BN Noureddin 2006 Intravitreal bevacizumab for the management of choroidal neovascularization in age-related macular degeneration Am J Ophthalmol 142 1 9 1:CAS:528:DC%2BD28Xms1GktLg%3D 10.1016/j.ajo.2006.02.037 16815245 (Pubitemid 43946791)
11. ES Gragoudas AP Adamis ET Cunningham Jr M Feinsod DR Guyer 2004 VEGF inhibition study in ocular neovascularization clinical trial group. Pegaptanib for neovascular age-related macular degeneration N Engl J Med 351 2805 2816 1:CAS:528:DC%2BD2MXhslyntw%3D%3D 10.1056/NEJMoa042760 15625332 (Pubitemid 40051904)
12. M Economopoulou K Bdeir DB Cines F Franz B Yasmina 2005 Inhibition of pathologic retinal neovascularization by alpha-defensins Blood 106 3831 3838 1:CAS:528:DC%2BD2MXht12ksbfJ 10.1182/blood-2005-03-0889 16123222 (Pubitemid 41739020)
13. O Konopatskaya AJ Churchill SJ Harper DO Bates TA Gardiner 2006 VEGF165b, an endogenous C-terminal splice variant of VEGF, inhibits retinal neovascularization in mice Mol Vis 12 626 632 1:CAS:528:DC%2BD28XntVelsrY%3D 16735996 (Pubitemid 43786776)
14. T Ojima H Takagi K Suzuma H Oh I Suzuma H Ohashi 2006 Ephrin A1 inhibits vascular endothelial growth factor-induced intracellular signaling and suppresses retinal neovascularization and blood-retinal barrier breakdown Am J Pathol 168 331 339 1:CAS:528:DC%2BD28XhtVKktrY%3D 10.2353/ajpath.2006.050435 16400034 (Pubitemid 43062584)
15. J Shen X Yang WH Xiao SF Hackett Y Sato PA Campochiaro 2006 Vasohibin is up-regulated by VEGF in the retina and suppresses VEGF receptor 2 and retinal neovascularization FASEB J 20 723 725 1:CAS:528:DC%2BD28XjtlGqsbg%3D 16473886 (Pubitemid 46671194)
16. X Xia S Xiong W Song J Luo Y Wang R Zhou 2008 Inhibition of retinal neovascularization by siRNA targeting VEGF165 Mol Vis 14 1965 1973 1:CAS:528:DC%2BD1cXhsVaqu73J 18978955
17. P Ghosh G Han De Mrinmoy CK Kim VM Rotello 2008 Gold nanoparticles in delivery applications Adv Drug Deliv Rev 60 1307 1315 1:CAS:528: DC%2BD1cXosVOnsrY%3D 10.1016/j.addr.2008.03.016 18555555
18. GF Paciotti L Myer D Weinreich D Goia N Pavel RE McLaughlin L Tamarkin 2004 Colloidal gold: a novel nanoparticle vector for tumor directed drug delivery Drug Deliv 11 169 183 1:CAS:528:DC%2BD2cXks1aiurc%3D 10.1080/10717540490433895 15204636 (Pubitemid 38720414)
19. J Davda V Labhasetwar 2002 Characterization of nanoparticle uptake by endothelial cells Int J Pharm 233 51 59 1:CAS:528:DC%2BD38XhslymsLg%3D 10.1016/S0378-5173(01)00923-1 11897410 (Pubitemid 34230418)
20. K Kalishwaralal E Banumathi SRK Pandian V Deepak J Muniyandi SH Eom S Gurunathan 2009 Silver nanoparticles inhibit VEGF-induced cell proliferation and migration in bovine retinal endothelial cells Colloid Surf B 73 51 57 1:CAS:528:DC%2BD1MXoslalt7Y%3D 10.1016/j.colsurfb.2009.04.025
21. K Kalimuthu RS Babu D Venkataraman M Bilal S Gurunathan 2008 Biosynthesis of silver nanocrystals by Bacillus licheniformis Colloids Surf B 65 150 153 1:CAS:528:DC%2BD1cXntlSnsL0%3D 10.1016/j.colsurfb.2008.02.018
22. K Kalishwaralal V Deepak S Ram Kumar Pandian S Gurunathan 2009 Biological synthesis of gold nanocubes from Bacillus licheniformis Bioresour Technol 100 5356 5358 1:CAS:528:DC%2BD1MXoslGgs70%3D 10.1016/j.biortech.2009.05.051 19574037
23. X Liu M Atwater J Wang Q Huo 2007 Extinction coefficient of gold nanoparticles with different sizes and different capping ligands Colloids Surf B 58 3 7 1:CAS:528:DC%2BD2sXlvVOksr0%3D 10.1016/j.colsurfb.2006.08.005 (Pubitemid 46783417)
24. E Banumathi R Haribalaganesh SSP Babu NS Kumar G Sangiliyandi 2009 High-yielding enzymatic method for isolation and culture of microvascular endothelial cells from bovine retinal blood vessels Microvasc Res 77 377 381 1:CAS:528:DC%2BD1MXktlyqsb8%3D 10.1016/j.mvr.2008.12.005 19233216
25. S Gurunathan KJ Lee K Kalishwaralal S Sheikpranbabu R Vaidyanathan SH Eom 2009 Antiangiogenic properties of silver nanoparticles Biomaterials 31 6341 6350 10.1016/j.biomaterials.2009.08.008
26. S Sheikpranbabu K Kalishwaralal D Venkataraman SH Eom J Park S Gurunathan 2009 Silver nanoparticles inhibit VEGF-and IL-1β-induced vascular permeability via Src dependent pathway in porcine retinal endothelial cells J Nanobiotechnol 7 8 10.1186/1477-3155-7-8
27. SA Kumar YA Peter JL Nadeau 2008 Facile biosynthesis, separation and conjugation of gold nanoparticles to doxorubicin Nanotechnology 19 495101 10.1088/0957-4484/19/49/495101
28. M Sastry V Patil SRJ Sainkar 1998 Electrostatically controlled diffusion of carboxylic acid derivatized silver colloidal particles in thermally evaporated fatty amine films Phys Chem B 102 1404 1410 1:CAS:528: DyaK1cXntFyjtw%3D%3D 10.1021/jp9719873 (Pubitemid 128600636)
29. BP Eliceiri R Paul PL Schwartzberg JD Hood J Leng DA Cheresh, et al. 1999 Selective requirement for Src kinases during VEGF-induced angiogenesis and vascular permeability Mol Cell 4 915 924 1:CAS:528:DC%2BD3cXislarsw%3D%3D 10.1016/S1097-2765(00)80221-X 10635317 (Pubitemid 30054898)
30. F Liu AD Verin P Wang R Day RP Wersto FJ Chrest, et al. 2001 Differential regulation of sphingosine-1-phosphate and VEGF-induced endothelial cell chemotaxis: involvement of G (ialpha2)-linked Rho kinase activity Am J Respir Cell Mol Biol 24 711 719 1:CAS:528:DC%2BD3MXltVWhsbc%3D 11415936 (Pubitemid 32550593)
31. R Paul ZG Zhang BP Eliceiri Q Jiang AD Boccia RL Zhang 2001 Src deficiency or blockade of Src activity in mice provides cerebral protection following stroke Nat Med 7 222 227 1:CAS:528:DC%2BD3MXhtVyks70%3D 10.1038/84675 11175854 (Pubitemid 32148490)
32. S Patan 2004 Vasculogenesis and angiogenesis Cancer Treat Res 117 3 32 1:CAS:528:DC%2BD2cXptFKiuro%3D 15015550
33. NS Harhaj DA Antonetti 2004 Regulation of tight junctions and loss of barrier function in pathophysiology Int J Biochem Cell Biol 36 1206 1237 1:CAS:528:DC%2BD2cXjsVWnsb8%3D 10.1016/j.biocel.2003.08.007 15109567 (Pubitemid 38519069)
34. JT Parsons SJ Parsons 1997 Src family protein tyrosine kinases: cooperating with growth factor and adhesion signaling pathways Curr Opin Cell Biol 9 187 192 1:CAS:528:DyaK2sXisVWntb0%3D 10.1016/S0955-0674(97)80062-2 9069259 (Pubitemid 27135986)
35. P Mukherjee R Bhattacharya P Wang L Wang S Basu JA Nagy 2005 Antiangiogenic properties of gold nanoparticles Clin Cancer Res 11 3530 3534 1:CAS:528:DC%2BD2MXjslOqtLc%3D 10.1158/1078-0432.CCR-04-2482 15867256 (Pubitemid 40627908)
36. S Murugesan SA Mousa LJ O'Connor DW Lincoln II RJ Linhardt 2007 Carbon inhibits vascular endothelial growth factor- and fibroblast growth factor promoted angiogenesis FEBS Lett 581 1157 1160 1:CAS:528:DC%2BD2sXjtFGrtro%3D 10.1016/j.febslet.2007.02.022 17331505 (Pubitemid 46385938)
37. A Nakashio N Fujita T Tsuruo 2002 Topotecan inhibits VEGF- and bFGF-induced vascular endothelial cell migration via downregulation of the PI3 K-Akt signaling pathway Int J Cancer 98 36 41 1:CAS:528:DC%2BD38Xht1WgsLY%3D 10.1002/ijc.10166 11857382 (Pubitemid 34113415)
38. L Favot T Keravis V Holl A Le Bec C Lugnier 2003 VEGF-induced HUVEC migration and proliferation are decreased by PDE2 and PDE4 inhibitors Thromb Haemost 90 334 343 1:CAS:528:DC%2BD3sXntFems7g%3D 12888882 (Pubitemid 36992510)
39. SM Thomas JS Brugge 1997 Cellular functions regulated by Src family kinases Annu Rev Cell Dev Biol 13 513 609 1:CAS:528:DyaK1cXisFSrsQ%3D%3D 10.1146/annurev.cellbio.13.1.513 9442882 (Pubitemid 28034534)
40. JS Nam Y Ino M Sakamoto S Hirohashi 2002 Src family kinase inhibitor PP2 restores the E cadherin/catenin cell adhesion system in human cancer cells and reduces cancer metastasis Clin Cancer Res 8 2430 2436 1:CAS:528: DC%2BD38XmtVWht7c%3D 12114449 (Pubitemid 34753619)
41. B Boyer Y Bourgeois MF Poupon 2002 Src kinase contributes to the metastatic spread of carcinoma cells Oncogene 21 2347 2356 1:CAS:528: DC%2BD38XivFykurg%3D 10.1038/sj.onc.1205298 11948418 (Pubitemid 34407294)
42. G Thurston C Suri K Smith J McClain TN Sato GD Yancopoulos DM McDonald 1999 Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1 Science 286 2511 2514 1:CAS:528:DC%2BD3cXntlan 10.1126/science.286.5449.2511 10617467 (Pubitemid 30026340)
43. H He VJ Venema X Gu RC Venema MB Marrero RB Caldwell 1999 Vascular endothelial growth factor signals endothelial cell production of nitric oxide and prostacyclin through flk-1/KDR activation of c-Src J Biol Chem 274 25130 25135 1:CAS:528:DyaK1MXls1ymu70%3D 10.1074/jbc.274.35.25130 10455194 (Pubitemid 29404726)
44. RB Irby W Mao D Coppola J Kang JM Loubeau W Trudeau 1999 Activating SRC mutation in a subset of advanced human colon cancers Nat Genet 21 187 190 1:CAS:528:DyaK1MXpsVCksA%3D%3D 10.1038/5971 9988270 (Pubitemid 29070364)
45. PP Simeonova S Wang T Hulderman MI Luster 2002 c-Src-dependent activation of the epidermal growth factor receptor and mitogen-activated protein kinase pathway by arsenic: role in carcinogenesis J Biol Chem 277 2945 2950 1:CAS:528:DC%2BD38XhtVSgtLo%3D 10.1074/jbc.M109136200 11723127 (Pubitemid 34953329)
46. MT Brown JA Cooper 1996 Regulation, substrates and functions of src Biochi Biophys Acta 1287 121 149 (Pubitemid 26189191)
47. CL Abram SA Courtneidge 2000 Src family tyrosine kinases and growth factor signaling Exp Cell Res 254 1 13 1:CAS:528:DC%2BD3cXht1ChsQ%3D%3D 10.1006/excr.1999.4732 10623460 (Pubitemid 30066726)
48. M Priyabrata B Resham B Nancy KL Yean P Chitta Ranjan W Shanfeng L Lichun S Charla CB Pataki JY Michael EK Neil 2007 Potential therapeutic application of gold nanoparticles in B-chronic lymphocytic leukemia (BCLL): enhancing apoptosis J Nanobiotechnol 5 4 10.1186/1477-3155-5-4 (Pubitemid 46851043)